NEXGEL Stock (NASDAQ:NXGL)

Revenue Ownership Financials Chart Transcripts

Previous Close

$2.81

52W Range

$1.46 - $3.24

50D Avg

$2.56

200D Avg

$2.35

Market Cap

$25.07M

Avg Vol (3M)

$49.17K

Beta

0.78

Div Yield

-

NXGL Company Profile

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

19

IPO Date

Dec 22, 2021

Website

NXGL Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 23
Contract Manufacturing	$1.98M
Other Incomes	$76.00K

Fiscal year ends in Dec 23 | Currency in USD

NXGL Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$4.09M	$2.05M	$1.55M
Operating Income	$-3.48M	$-3.35M	$-2.57M
Net Income	$-3.16M	$-6.14M	$-6.31M
EBITDA	$-3.03M	$-3.04M	$-2.46M
Basic EPS	$-0.56	$-1.10	$-1.13
Diluted EPS	$-0.56	$-1.10	$-1.13

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q2 24Aug 14, 24 | 9:01 PM

Q1 24May 13, 24 | 12:00 AM

Q4 23Apr 01, 24 | 2:25 PM

Peer Comparison

Ticker	Company
ZJYL	Jin Medical International Ltd.
AVGR	Avinger, Inc.
GMVD	G Medical Innovations Holdings Ltd
GCTK	GlucoTrack, Inc.
POAI	Predictive Oncology Inc.
LUCY	Innovative Eyewear, Inc.
DXR	Daxor Corporation
PDEX	Pro-Dex, Inc.
NYXH	Nyxoah S.A.
STSS	Sharps Technology, Inc.